Federica Ottolini

No ORCID on file · 9 papers in corpus
rct 2026
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2026.115381

Pain is a defining symptom of endometriosis reducing quality of life and increasing the risk of psychological disorders. We conducted an open-label, randomized, controlled trial to investigate whether structured coaching on Mediterranean di…

observational 2025
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-08006-6

PURPOSE: Although thoracic endometriosis (TE) represents the most common manifestation of extra-pelvic endometriosis, it is a rare condition and currently there is no established clinical guideline for the management of this condition. The …

observational 2022
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-022-01009-7

AGD is the distance measured from the anus to the genital tubercle. Recent evidence suggests that a shorter AGD, a sensitive biomarker of the prenatal hormonal environment, could be associated with higher endometriosis risk. However, studie…

observational 2021
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2021.08.011

RESEARCH QUESTION: What are the associations between endometriosis, pelvic pain symptoms, fatigue and sleep? Psychological health and quality of life in endometriosis patients with good versus bad quality of sleep were also examined. DESIG…

observational 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.01.037

OBJECTIVE: To assess the proportion of patients with symptomatic endometriosis satisfied with their medical treatment 12 months after enrollment in a stepped-care management protocol. DESIGN: Prospective, single-arm, self-controlled study.…

other 2018
Human Reproduction ·doi:10.1093/humrep/dey368

Elagolix, an orally active non-peptidic GnRH antagonist, has been approved by the Food and Drug Administration for the management of moderate to severe pain associated with endometriosis. As the degree of ovarian suppression obtained with e…

nonrandomized-trial 2018
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719117749759

The purpose of this study was to assess the proportion of patients satisfied with their treatment after a change from a low-dose oral contraceptive (OC) to norethisterone acetate (NETA) because of inefficacy of OC on pain symptoms. To this …

observational 2018
Gynecologic and obstetric investigation ·doi:10.1159/000494254

AIMS: The economic burden of endometriosis and pelvic pain involves direct and indirect healthcare costs due to work loss and decreased productivity. However, the relation between endometriosis, pelvic pain, and employment remains underinve…

nonrandomized-trial 2018
Gynecologic and obstetric investigation ·doi:10.1159/000486335

BACKGROUND/AIMS: Oral contraceptives (OC) and norethisterone acetate (NETA) are among first-line medical therapies for symptomatic endometriosis, but their use is sometimes associated with intolerable side effects. We investigated whether s…